If you're in search for a bioanalytical partner to help advance your pre-clinical or clinical development program, look no further. Discover the bioanalytical difference at Worldwide! https://ow.ly/XziY50Sv484
Worldwide Clinical Trials’ Post
More Relevant Posts
-
Hear from the 2024 Annual Meeting's Abstract Directors, Hannah Zierden, PhD, and Alexandros Marios Sofias, PhD, as they highlight the incredible stats we've seen with this year's abstract submissions. You can view the full Abstract topics overview here: https://ow.ly/ig0B50SmIFU #CRS2024 #deliveryscience #pharma #drugdelivery #scientist #scienceandtechnology #researchandevelopment
To view or add a comment, sign in
-
Case Study: The Impact of Cell Validation Consider a scenario where a research team is investigating a new drug’s effects on liver cells. Without validation, there is a risk that the cells used are contaminated or misidentified, leading to erroneous conclusions about the drug’s efficacy or toxicity. However, with validated hepatic cells from Vesta Bio, the research team can confidently proceed with their experiments, knowing their cells are authentic, pure, and functional. This assurance results in reliable data, successful publication, and a smoother path to potential drug development. Learn more about Vesta's cell validation services today! www.vestabiotx.com
To view or add a comment, sign in
-
#HCS_Software_and_Services Market Share Expected Huge Growth during 2022-2030 https://lnkd.in/d5v3YnnS Growing drug #discovery research owing to rising disease burden will be influencing the #growth of the market. High-content screening is a well-established approach for the #multiparametric analysis of cellular events. To get more from #biological and #clinical research, many scientists rely on high-content screening (HCS). GE GE HealthCare Thermo Fisher Scientific Hill Dickinson LLP Becton Dickenson Yokogawa Electric Corporation
To view or add a comment, sign in
-
POINTS TO REMEMBER Ultrapure Reagents There are several types of ultrapure reagents. For the clinical laboratory, they are referred to as reference materials. There are several different types of reference materials: • Primary reference materials • Secondary reference materials • Standard reference materials • Certified reference materials
To view or add a comment, sign in
-
Start the year off right by checking out our web post on "Optimizing Fragment-Based Drug Discovery by NMR." This piece shares some cool insights on making drug discovery more effective using NMR techniques. 👉 https://bit.ly/3tvq3ak 👈 Plus, don't miss out on catching up with one of our recent webinars given by AbbVie's speaker. The recorded session is right there within the web post. It's a great way to kickstart the year with inspiration and knowledge! Wishing you an amazing and successful year ahead! #analyticalchemistry #FBDD #DrugDiscovery #MnovaRocks #ligandbinding #NMR #screening
To view or add a comment, sign in
-
[Live webinar alert!] Inside the technical note. Chapter 3 Join us for the final 'Inside the technical note' live webinar. where we unveil the latest technical notes and explore the secrets behind their discoveries. Technical notes covered: - Development of an acetylcholinesterase biochemical assay using the SCIEX Echo® MS system -Enhanced drug metabolite identification using collision-induced dissociation (CID) and electron-activated dissociation (EAD) -A sensitive method for the quantitation of bimatoprost in human plasma Register today! https://bit.ly/3uCFHk7 #SCIEX #DrugDevelopment
Chapter 3: Inside the technical note
sciex.com
To view or add a comment, sign in
-
In case you have missed it, here is the #published article on our #Pharmaceuticals 😻 Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors by Ábrányi-Balogh et al. Enjoy reading: https://lnkd.in/gkhn_cqx
Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors
mdpi.com
To view or add a comment, sign in
-
At what stage do you introduce biophysical tools into your drug discovery workflow? Traditionally, they’re used late in the workflow to validate hits after biochemical assays, but a new paper (https://lnkd.in/gFtT3Cqi) out of Amgen indicates that they should be used earlier in HTS. Here’s 3 reasons why: 1️⃣ Higher quality hits: Biophysically confirmed hits have higher quality-control metrics and better specificity than unconfirmed hits. 2️⃣ Increased efficiency: Introducing biophysical tools earlier streamlines the screening process, reducing time spent on false positives. 3️⃣ Improved predictive power: Getting better data earlier in the process ensures that the candidates that move forward have the best chance of making it to the clinic. Looking for a biophysical method to add to your early HTS workflow? Learn about one of the instruments mentioned in the paper — Dianthus — and how it provides in-solution and mass-independent affinity measurements: https://bit.ly/3RU6mlx
To view or add a comment, sign in
-
Solutions to Modern Bioanalytical Laboratory Challenges In this video, Kenneth Swart, MMedSc, PhD, discusses the challenges and solutions in modern bioanalytical laboratories amid the rise of novel biotherapeutics. Watch the Video: https://lnkd.in/eNSmT5af
Solutions to Modern Bioanalytical Laboratory Challenges
biopharminternational.com
To view or add a comment, sign in
163,121 followers